Breast Cancer Coverage From Every Angle
Advertisement
Advertisement

Active CE Activities

Oncology Grand Rounds Series: Part 3 — Breast Cancer: A satellite symposium held at the 2017 ONS Annual Congress
What Would You Do? Managing HR-Positive Advanced Breast Cancer
2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Breast Cancer
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast Cancer
Management of HR-Positive Advanced Breast Cancer: Is There a Best Sequence?
Medical Crossfire®: Expert Perspectives on the Emerging Role of CDK4/6 Inhibitors for the Management of Metastatic Breast Cancer
Evolving Standards in HER2-Targeted Adjuvant Therapy
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™
Recorded Presentations From the NCCN 2017 Congress Webinar Series: Breast Cancer
Taxane-Based Tx May Put Breast Ca Patients Off Balance
CDK4/6 Inhibitors: Moving Beyond the Breast Cancer Setting
Hormone Receptor-Positive Advanced Breast Cancer: Will ESR1 Have a Role?
Response to PD-L1 Drug Boosts Survival in TNBC
Adding Evidence to Front-Line Therapy of Hormone Receptor–Positive Breast Cancer
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
NCCN Continuing Education in Breast Cancer
HER2-Negative Metastatic Breast Cancer: Can We Delay Time to Chemotherapy?
14th Annual School of Breast Oncology® Online